Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease

Biomarkers

Volumn 19, Issue 5, 2014, Pages 368-377

  Nakamura, Miho ^a   Nakamura, Hidetoshi ^a,b   Minematsu, Naoto ^a   Chubachi, Shotaro ^a   Miyazaki, Masaki ^a   Yoshida, Shuichi ^a   Tsuduki, Keishi ^a   Shirahata, Toru ^a   Mashimo, Shuko ^a   Takahashi, Saeko ^a   Nakajima, Takahiro ^a   Tateno, Hiroki ^a   Fujishima, Seitaro ^a   Betsuyaku, Tomoko ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Airflow limitation; Chronic obstructive pulmonary disease; Emphysema; Inflammatory cytokine; Plasma biomarker

Indexed keywords

ADIPONECTIN; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; BIOLOGICAL MARKER;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CROSS-SECTIONAL STUDY; DYSPNEA; EMPHYSEMA; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN TISSUE; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; PHENOTYPE; PROTEIN BLOOD LEVEL; SMOKING; AGED; BLOOD; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; STATISTICAL MODEL;

AGED; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-5; INTERLEUKIN-6; INTERLEUKIN-7; LOGISTIC MODELS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84904701248     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.915342     Document Type: Article

References (39)

1. Agusti A, Edwards LD, Rennard SI, et al. (2012). Persistent systemic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype. PLoS One 7:e37483.
2. Agusti AG, Noguera A, Sauleda J, et al. (2003). Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21:347-60.
3. American Thoracic Society. (1995). Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152:1107-36.
4. Barnes PJ. (2004). Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 56:515-48.
5. Barnes PJ. (2008). The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 118:3546-56.
6. Barnes PJ, Chowdhury B, Kharitonov SA, et al. (2006). Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174:6-14.
7. Barnes PJ, Shapiro SD, Pauwels RA. (2003). Chronic obstructive pulmonary disease: Molecular and cellular mechanisms. Eur Respir J 22:672-88.
8. Bon JM, Leader JK, Weissfeld JL, et al. (2009). The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS One 4:e6865.
9. Dienz O, Rincon M. (2009). The effects of IL-6 on CD4 T cell responses. Clin Immunol (Orlando) 130:27-33.
10. Donaldson GC, Seemungal TA, Patel IS, et al. (2005). Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 128:1995-2004.
11. Drannik AG, Pouladi MA, Robbins CS, et al. (2004). Impact of cigarette smoke on clearance and inflammation after Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 170:1164-71.
12. Elias J. (2004). The relationship between asthma and COPD. Lessons from transgenic mice. Chest 126:111S-16S; discussion 159S-61S.
13. Fletcher C, Peto R. (1977). The natural history of chronic airflow obstruction. Br Med J 1:1645-8.
14. Gan WQ, Man SF, Senthilselvan A, Sin DD. (2004). Association between chronic obstructive pulmonary disease and systemic inflammation: A systematic review and a meta-Analysis. Thorax 59:574-80.
15. Gan WQ, Man SF, Sin DD. (2005). The interactions between cigarette smoking and reduced lung function on systemic inflammation. Chest 127:558-64.
16. Garcia-Rio F, Miravitlles M, Soriano JB, et al. (2010). Systemic inflammation in chronic obstructive pulmonary disease: A populationbased study. Respir Res 11:63. doi: 10.1186/1465-9921-11-63.
17. Goddard PR, Nicholson EM, Laszlo G, Watt I. (1982). Computed tomography in pulmonary emphysema. Clin Radiol 33:379-87.
18. Graff JW, Powers LS, Dickson AM, et al. (2012). Cigarette smoking decreases global microRNA expression in human alveolar macrophages. PLoS One 7:e44066.
19. Hogg JC, Chu F, Utokaparch S, et al. (2004). The nature of small-Airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645-53.
20. Kolsum U, Roy K, Starkey C, et al. (2009). The repeatability of interleukin-6, tumor necrosis factor-Alpha, and c-reactive protein in COPD patients over one year. Int J Chron Obstruct Pulmon Dis 4: 149-56.
21. Letuve S, Kozhich A, Arouche N, et al. (2008). YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages. J Immunol 181:5167-73.
22. Liang R, Zhang W, Song YM. (2013). Levels of leptin and IL-6 in lungs and blood are associated with the severity of chronic obstructive pulmonary disease in patients and rat models. Mol Med Rep 7: 1470-6.
23. MacNee W. (2005). Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:258-66; discussion 290-1.
24. Makita H, Nasuhara Y, Nagai K, et al. (2007). Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 62:932-7.
25. Man SF, Sin DD. (2005). Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2:78-82.
26. Minematsu N, Nakamura H, Iwata M, et al. (2003). Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema. Thorax 58:623-8.
27. Mishima M, Hirai T, Itoh H, et al. (1999). Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 96:8829-34.
28. Nakano Y, Muller NL, King GG, et al. (2002). Quantitative assessment of airway remodeling using high-resolution CT. Chest 122: 271S-5S.
29. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2003) Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease. Available from: Http://www.goldcopd.org.
30. Pinto-Plata V, Toso J, Lee K, et al. (2007). Profiling serum biomarkers in patients with COPD: Associations with clinical parameters. Thorax 62: 595-601.
31. Pinto-Plata VM, Mullerova H, Toso JF, et al. (2006). C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 61: 23-8.
32. Saetta M, Turato G, Maestrelli P, et al. (2001). Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:1304-9.
33. Shapiro SD. (2001). End-stage chronic obstructive pulmonary disease: The cigarette is burned out but inflammation rages on. Am J Respir Crit Care Med 164:339-40.
34. Shaykhiev R, Krause A, Salit J, et al. (2009). Smoking-dependent reprogramming of alveolar macrophage polarization: Implication for pathogenesis of chronic obstructive pulmonary disease. J Immunol 183:2867-83.
35. Sin DD, Man SF. (2006). Skeletal muscle weakness, reduced exercise tolerance, and COPD: Is systemic inflammation the missing link? Thorax 61:1-3
36. Stoger JL, Gijbels MJ, van der Velden S, et al. (2012). Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 225:461-8.
37. Wannamethee SG, Lowe GD, Shaper AG, et al. (2005). Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 26:1765-73.
38. Wedzicha JA, Seemungal TA, MacCallum PK, et al. (2000). Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels. Thromb Haemost 84:210-15.
39. Zhang J, Liu Y, Shi J, et al. (2002). Side-stream cigarette smoke induces dose-response in systemic inflammatory cytokine production and oxidative stress. Exp Biol Med (Maywood) 227:823-9.